D R Budman|M L Citron - JoVE Visualize

Showing results (91-100 of 120) with videos related to

Pageof 12

Sort By:

Annals of Internal Medicine|December 1, 1978

Increased risk of lymphoma in sicca syndromeS S Kassan, T L Thomas, H M Moutsopoulos, et al.

Cancer Chemotherapy and Pharmacology|July 19, 2001

Phase I and pharmacokinetic study of LY309887: a specific inhibitor of purine biosynthesisD R Budman, R Johnson, B Barile, et al.

Southern Medical Journal|March 1, 1988

Lung cancer, tuberculin reactivity, and isoniazidM M Alhashimi, M L Citron, B E Fossieck, et al.

Cancer Treatment Reports|January 1, 1985

Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomitingM L Citron, T S Herman, F Vreeland, et al.

Leukemia|May 1, 1991

Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB StudyJ Cuttner, R Mick, D R Budman, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 30, 2000

Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New YorkS D Stellman, M V Djordjevic, J A Britton, et al.

Journal of the National Cancer Institute|August 18, 1993

Phase I trial of granulocyte-macrophage colony-stimulating factor plus high-dose cyclophosphamide given every 2 weeks: a Cancer and Leukemia Group B studyS M Lichtman, M J Ratain, D A Van Echo, et al.

The New England Journal of Medicine|May 5, 1994

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancerH B Muss, A D Thor, D A Berry, et al.

Bone Marrow Transplantation|November 1, 1996

Phase I study of high-dose etoposide phosphate in manS Z Fields, D R Budman, R R Young, et al.

The New England Journal of Medicine|May 5, 1994

Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinomaW C Wood, D R Budman, A H Korzun, et al.

Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:

Pageof 12

Annals of Internal Medicine|December 1, 1978

Increased risk of lymphoma in sicca syndromeS S Kassan, T L Thomas, H M Moutsopoulos, et al.

Cancer Chemotherapy and Pharmacology|July 19, 2001

Phase I and pharmacokinetic study of LY309887: a specific inhibitor of purine biosynthesisD R Budman, R Johnson, B Barile, et al.

Southern Medical Journal|March 1, 1988

Lung cancer, tuberculin reactivity, and isoniazidM M Alhashimi, M L Citron, B E Fossieck, et al.

Cancer Treatment Reports|January 1, 1985

Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomitingM L Citron, T S Herman, F Vreeland, et al.

Leukemia|May 1, 1991

Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB StudyJ Cuttner, R Mick, D R Budman, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 30, 2000

Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New YorkS D Stellman, M V Djordjevic, J A Britton, et al.

Journal of the National Cancer Institute|August 18, 1993

The New England Journal of Medicine|May 5, 1994

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancerH B Muss, A D Thor, D A Berry, et al.

Bone Marrow Transplantation|November 1, 1996

Phase I study of high-dose etoposide phosphate in manS Z Fields, D R Budman, R R Young, et al.

The New England Journal of Medicine|May 5, 1994

Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinomaW C Wood, D R Budman, A H Korzun, et al.

Pageof 12